2019
DOI: 10.3889/oamjms.2019.157
|View full text |Cite
|
Sign up to set email alerts
|

The The Influence of Wharton Jelly Mesenchymal Stem Cell toward Matrix Metalloproteinase-13 and RELA Synoviocyte Gene Expression on Osteoarthritis

Abstract: BACKGROUND: Therapy for osteoarthritis (OA) with satisfactory results has not been found to date. In OA pathogenesis, RELA gene involved in cartilage degradation and MMP-13 in degrade cartilage, as a member family of NF-ĸβ genes, RELA serves to modulate inflammatory responses and activates pro-inflammatory cytokines. AIM: This study aims to identify the influence of Wharton Jelly Mesenchymal Stem Cell (MSC-WJ) on MMP-13 and RELA expression gene in synoviocyte by in vitro. MATERIAL AND METHODS: This… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 13 publications
0
6
0
Order By: Relevance
“…The addition of Wharton's jelly to synoviocytes isolated from human knees with grade IV osteoarthritis reduced the expression of MMP-13 and RELA. The findings were statistically significant compared to the synoviocyte control [27].…”
Section: Osteoarthritismentioning
confidence: 72%
“…The addition of Wharton's jelly to synoviocytes isolated from human knees with grade IV osteoarthritis reduced the expression of MMP-13 and RELA. The findings were statistically significant compared to the synoviocyte control [27].…”
Section: Osteoarthritismentioning
confidence: 72%
“…The addition of WJ to synoviocytes from pre-TKA human knees with grade IV OA showed a reduction in the expression of MMP-13 and RELA. These findings were statistically significant when compared to the control with only synoviocytes [ 35 ].…”
Section: Resultsmentioning
confidence: 99%
“…Beside their direct effects on cartilage cells, wjMSCs act also on other articular cells, such as synovial fibroblasts, playing a key role in synovitis. Indeed, synovial fibroblasts from either OA or RA patients cocultured with wjMSCs showed a reduced expression of inflammatory molecules and matrix-degrading enzymes as compared to synovial fibroblasts in control conditions, associated with a higher production of cartilage matrix proteins collagen II and aggrecan in fibroblasts [45][46][47]. These results have been confirmed also in a horse model of synovitis, in which the injection of allogeneic cbMSCs led to a decrease in the number of immune cells in the synovial fluid as compared to the control, showing the possibility to reduce inflammation and associated immune cell recruitment [48].…”
Section: Cord Blood and Wharton's Jelly Mscs For Oa And Ra Therapymentioning
confidence: 99%